VIMAB Group AB (publ) OMXSTO:VIMAB:
Q4 NET SALES FOR THE PERIOD AMOUNTED TO SEK 86.6 MILLION (85.7)
Q4 OPERATING PROFIT, EXCLUDING DIVESTMENT OF HUNGARIAN SUBSIDIARY, AMOUNTED TO SEK -34.1 MILLION (-47.1)
Vimab Group Q4 Net Sales SEK 86.6 Mln
Earlier from Vimab Group Ab
- Vimab Group Announces Preliminary Outcome Of Rights Issue
- Sagri Development, Aerix Industri Cancel Deal On Acquisition Of Vimab Ab
- Vimab Group Resolves On Rights Issue Of SEK 127.4 Mln
- Aerix Replaces Grimaldi As Acquirer Of Vimab AB